pancreatic ductal carcinoma (Cancer)
Information
- Disease name
- pancreatic ductal carcinoma
- Disease ID
- DOID:3587
- Description
- "A pancreatic carcinoma located_in the pancreatic duct." [url:http\://en.wikipedia.org/wiki/Pancreatic_cancer, url:http\://en.wikipedia.org/wiki/Pancreatic_duct]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04596865 | Completed | Recurrence After Whipple's (RAW) Study | October 12, 2020 | June 30, 2023 | |
| NCT06428409 | Not yet recruiting | Phase 2 | A Clinical Study of MK-2870 Alone or With Chemotherapy to Treat Gastrointestinal Cancers (MK-9999-02A) | June 19, 2024 | December 3, 2028 |
| NCT05288205 | Recruiting | Phase 1/Phase 2 | Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation | April 14, 2022 | March 2026 |
| NCT04121286 | Recruiting | Phase 1 | A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China | June 10, 2020 | December 2023 |
| NCT05293496 | Recruiting | Phase 1 | A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors | April 19, 2022 | March 2026 |
| NCT06182072 | Recruiting | Phase 1 | ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) | September 14, 2023 | October 1, 2025 |
| NCT02243007 | Terminated | Phase 2 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | September 2014 | June 2016 |
| NCT02715804 | Terminated | Phase 3 | A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma | March 14, 2016 | November 4, 2019 |
| NCT04045496 | Unknown status | Phase 1 | A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors | September 26, 2019 | March 2024 |
- Disase is a (Disease Ontology)
- DOID:4905
- Cross Reference ID (Disease Ontology)
- ICD10CM:C25.3
- Cross Reference ID (Disease Ontology)
- ICD9CM:157.3
- Cross Reference ID (Disease Ontology)
- MESH:D021441
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93939009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153461
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0887833
- Exact Synonym (Disease Ontology)
- malignant neoplasm of duct of Wirsung
- Exact Synonym (Disease Ontology)
- pancreatic duct cancer